George Graham - 11 Feb 2026 Form 4 Insider Report for BALCHEM CORP (BCPC)

Reporting relationship: SVP and Chief R&D Officer
Issuer ticker: BCPC
Reported as of: 11 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Feb 2026, 18:40:33 UTC
Prior SEC filing: 22 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/ Travis Larsen, Attorney in Fact for George Graham

Key filing fact

George Graham filed Form 4 for BALCHEM CORP (BCPC) on 13 Feb 2026.

Key facts

This page summarizes George Graham's Form 4 filing for BALCHEM CORP (BCPC).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 13 Feb 2026, 18:40.

Change

Previous filing in this sequence was filed on 22 Oct 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002082308 Primary reporting owner

Graham George

Relationship: SVP and Chief R&D Officer
Address: C/O BALCHEM CORPORATION, 5 PARAGON DRIVE, MONTVALE
Signature: /s/ Travis Larsen, Attorney in Fact for George Graham
Signature date: 13 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BCPC transaction

Common Stock

Award

Transaction value: $0
Shares: +700
Change %: +28%
Price: $0.000000
Shares after: 3,200
Date: 11 Feb 2026
Ownership: Direct
Footnotes: F1

BCPC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 20
Date: 11 Feb 2026
Ownership: 401(k) Plan

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BCPC transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +2,600
Change %
Price: $0.000000
Shares after: 2,600
Date: 11 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,600
Exercise price: $178.68
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.

Footnote F2

Options vest 20% Year 1, 40% Year 2, and 40% Year 3.